title: Efficacy, safety and pharmacokinetics of clofarabine in Chinese pediatric patients with refractory or relapsed acute lymphoblastic leukemia: a phase II, multi-center study.
authors.affiliation: Department of Pediatrics, Peking University People's Hospital, Beijing, China.
authors.forename: A
authors.initials: A
authors.lastname: Lu
authors.affiliation: Department of Phase 1 Clinical Trial, Peking University People's Hospital, Beijing, China.
authors.forename: Y
authors.initials: Y
authors.lastname: Fang
authors.affiliation: Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.
authors.forename: X
authors.initials: X
authors.lastname: Du
authors.affiliation: The First Hospital of China Medical University, Shenyang, China.
authors.forename: Y
authors.initials: Y
authors.lastname: Li
authors.affiliation: The First Affiliated Hospital, Zhejiang University, Hangzhou, China.
authors.forename: Z
authors.initials: Z
authors.lastname: Cai
authors.affiliation: The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
authors.forename: K
authors.initials: K
authors.lastname: Yu
authors.affiliation: Department of Phase 1 Clinical Trial, Peking University People's Hospital, Beijing, China.
authors.forename: L
authors.initials: L
authors.lastname: Zhao
authors.affiliation: Department of Pediatrics, Peking University People's Hospital, Beijing, China.
authors.forename: B
authors.initials: B
authors.lastname: Wang
authors.affiliation: Department of Pediatrics, Peking University People's Hospital, Beijing, China.
authors.forename: J
authors.initials: J
authors.lastname: Wu
authors.affiliation: Department of Pediatrics, Peking University People's Hospital, Beijing, China.
authors.forename: Y
authors.initials: Y
authors.lastname: Cheng
authors.affiliation: Department of Pediatrics, Peking University People's Hospital, Beijing, China.
authors.forename: Y
authors.initials: Y
authors.lastname: Zuo
authors.affiliation: Department of Pediatrics, Peking University People's Hospital, Beijing, China.
authors.forename: Y
authors.initials: Y
authors.lastname: Jia
authors.affiliation: Betta Pharmaceuticals Co., Ltd, Hangzhou, China.
authors.forename: F
authors.initials: F
authors.lastname: Tan
authors.affiliation: Betta Pharmaceuticals Co., Ltd, Hangzhou, China.
authors.forename: L
authors.initials: L
authors.lastname: Ding
authors.affiliation: Institute of Hematology, Peking University People's Hospital, Beijing, China.
authors.forename: J
authors.initials: J
authors.lastname: Lu
authors.affiliation: Department of Pediatrics, Peking University People's Hospital, Beijing, China.
authors.forename: L
authors.initials: L
authors.lastname: Zhang
authors.affiliation: Institute of Hematology, Peking University People's Hospital, Beijing, China.
authors.forename: X
authors.initials: X
authors.lastname: Huang
mesh_terms: D000227:Adenine Nucleotides / Q000494:pharmacology* / Q000627:therapeutic use*; D000293:Adolescent; D001087:Arabinonucleosides / Q000494:pharmacology* / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D000077866:Clofarabine; D019008:Drug Resistance, Neoplasm; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology*; D012008:Recurrence; D016896:Treatment Outcome
chemical_list: D000227:Adenine Nucleotides; D001087:Arabinonucleosides; D000077866:Clofarabine